Weekly insulin shot could replace daily injections for diabetes
NCT ID NCT06767748
First seen Nov 21, 2025 · Last updated Jun 13, 2026 · Updated 24 times
Summary
This study tests a new insulin (GZR4) that is injected just once a week, compared to a standard daily insulin (degludec), in 620 adults with type 2 diabetes who already use basal insulin. The goal is to see if the weekly shot controls blood sugar just as well or better, with fewer injections and similar safety. Participants may also take other non-insulin diabetes medicines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gan & Lee Pharmaceuticals Shandong Co., Ltd.
Linyi, Shandong, 276000, China
Conditions
Explore the condition pages connected to this study.